AAQ1 — Aap Implantate AG Share Price
Last Trade - 00:00- €10.98m
- €13.14m
- €10.12m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 31st Dec | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 10.49 | 10.9 | 10.78 | 11.74 | 9.33 | 10.6 | 12 | -5.35% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
aap Implantate AG is a Germany-based provider of medical devices for human muscular and skeletal systems. The Company focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . It also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The Company operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
Directors
- Nathalie Krebs (47)
- Rubino Di Girolamo CMG (57)
- Jacqueline Rijsdijk (61)
- Marek Hahn (43)
- Biense Visser SUB (66)
- Last Annual
- December 31st, 2020
- Last Interim
- June 30th, 2020
- Incorporated
- January 1st, 1970
- Public Since
- May 10th, 1999
- No. of Employees
- 102
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- XETRA
- Shares in Issue
- 3,138,445
- Address
- Lorenzweg 5, BERLIN, 12099
- Web
- https://www.aap.de/
- Phone
- +49 30750190
- Auditors
- Mazars GmbH Wirtschaftsprufungsgesellschaft
Latest News for AAQ1
Upcoming events for AAQ1
Q3 2021 Aap Implantate AG Earnings Release
Similar to AAQ1
FAQ
As of Today at 19:53 UTC, shares in Aap Implantate AG are trading at €3.50. This share price information is delayed by 15 minutes.
Shares in Aap Implantate AG last closed at €3.50 and the price had moved by +6.06% over the past 365 days. In terms of relative price strength the Aap Implantate AG share price has underperformed the FTSE Global All Cap Index by -17.65% over the past year.
The overall consensus recommendation for Aap Implantate AG is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Aap Implantate AG does not currently pay a dividend.
Aap Implantate AG does not currently pay a dividend.
Aap Implantate AG does not currently pay a dividend.
To buy shares in Aap Implantate AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €3.50, shares in Aap Implantate AG had a market capitalisation of €10.98m.
Here are the trading details for Aap Implantate AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: AAQ1
Shares are classified based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Aap Implantate AG does not currently have a style classification.
The analyst consensus target price for shares in Aap Implantate AG is €3.77. That is 7.71% above the last closing price of €3.50.
Analysts covering Aap Implantate AG currently have a consensus Earnings Per Share (EPS) forecast of -€0.88 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aap Implantate AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -9.03%.
As of the last closing price of €3.50, shares in Aap Implantate AG were trading +14.85% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Aap Implantate AG.
Aap Implantate AG's management team is headed by:
- Nathalie Krebs -
- Rubino Di Girolamo - CMG
- Jacqueline Rijsdijk -
- Marek Hahn -
- Biense Visser - SUB
We do not have data on Aap Implantate AG's shareholders